|
72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study |
|
|
|
Title: |
72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study |
Author: |
Malaba, Thokozile R Nakatudde, Irene Kintu, Kenneth Colbers, Angela Chen, Tao Reynolds, Helen Read, Lucy Read, Jim Stemmet, Lee-Ann Mrubata, Megan Byrne, Kelly Seden, Kay Twimukye, Adelline Theunissen, Helene Hodel, Eva Maria Chiong, Justin Hu, Nai-Chung Burger, David Wang, Duolao Byamugisha, Josaphat Alhassan, Yussif Bokako, Sharon Waitt, Catriona Taegtmeyer, Miriam Orrell, Catherine Lamorde, Mohammed Myer, Landon Khoo, Saye |
Appeared in: |
The Lancet. HIV |
Paging: |
Volume 9 () nr. 8 pages e534-e543 |
Year: |
2022 |
Contents: |
|
Publisher: |
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|